ATOS And BASILIX CERT On The List Of Winners And Losers Of Wednesday’s Euronext Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are ATOS, ESTORIL SOL N, and VIVORYON.

Financial Asset Price Change Updated (EST)
ATOS (ATO.PA) 1.71 51.89% 2024-06-19 12:45:55
ESTORIL SOL N (ESON.LS) 5.95 8.18% 2024-06-19 12:23:10
VIVORYON (VVY.AS) 2.10 6.13% 2024-06-19 12:04:28
ALMUNDA PRO NV (AMUND.AS) 1.30 5.69% 2024-06-19 12:00:24
ATLANTIC SAPPHIRE (ASA.OL) 8.89 5.56% 2024-06-19 12:24:46
OCEANTEAM (OTS.OL) 1.00 5.04% 2024-06-19 12:41:46
VÅR ENERGI (VAR.OL) 36.27 4.83% 2024-06-19 12:44:14
UMICORE (UMI.BR) 14.65 4.72% 2024-06-19 12:21:52
HØLAND OG SETSKOG (HSPG.OL) 124.98 4.17% 2024-06-19 12:40:32
FUT.CLUBE PORTO (FCP.LS) 1.30 4% 2024-06-19 12:23:14

The three biggest losers today are BASILIX CERT, ABIONYX PHARMA, and ADUX.

Financial Asset Price Change Updated (EST)
BASILIX CERT (BAS.BR) 9.50 -7.77% 2024-06-19 12:05:01
ABIONYX PHARMA (ABNX.PA) 1.28 -7.63% 2024-06-19 12:44:38
ADUX (ADUX.PA) 1.56 -6.89% 2024-06-19 12:45:00
AB SCIENCE (AB.PA) 1.13 -5.99% 2024-06-19 12:44:32
CELYAD ONCOLOGY (CYAD.BR) 0.29 -5.17% 2024-06-19 12:05:29
ADOCIA (ADOC.PA) 7.05 -4.88% 2024-06-19 12:44:56
AUTOSTORE HOLDINGS (AUTO.OL) 14.11 -4.86% 2024-06-19 12:24:52
ARTEA (ARTE.PA) 9.25 -4.64% 2024-06-19 12:45:44
ARRIBATEC GROUP (ARR.OL) 4.28 -4.46% 2024-06-19 12:24:41
HYDROGENPRO (HYPRO.OL) 10.22 -4.31% 2024-06-19 12:40:29

Winners today

1. ATOS (ATO.PA)

51.89% Price Change

Atos SE provides digital transformation solutions and services worldwide. It offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and Internet of things solutions; and modern applications and platforms. The company also provides advance detection and response, data protection and governance, digital workplace security, IoT and OT security, trusted digital identities, and cybersecurity solutions; and infrastructure and foundation services. It serves financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, resources and services, and telecommunication and media industries. The company was incorporated in 1982 and is headquartered in Bezons, France.

CAC 40 ended the session with ATOS jumping 51.89% to €1.71 on Wednesday, after three consecutive sessions in a row of gains. CAC 40 dropped 0.77% to €7,570.20, after two successive sessions in a row of gains, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, ATOS has a trailing twelve months EPS of €-31.04.

More news about ATOS.

2. ESTORIL SOL N (ESON.LS)

8.18% Price Change

Estoril Sol, SGPS, S.A., together with its subsidiaries, engages in the gaming activities and real estate businesses in Portugal and internationally. It owns gaming casinos, including casino do Estoril, Casino Lisboa, and Casino da Póvoa. It is also involved in the online casino games and gambling business, as well as online sports betting activities. In addition, it owns a plot of land in Monte Estoril. Further, the company engages in tourism business. The company was incorporated in 1958 and is headquartered in Estoril, Portugal. Estoril Sol, SGPS, S.A. is a subsidiary of Finansol – Sociedade de Controlo, SGPS, S.A.

PSI ended the session with ESTORIL SOL N rising 8.18% to €5.95 on Wednesday, after five successive sessions in a row of losses. PSI fell 0.44% to €6,541.80, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, ESTORIL SOL N has a trailing twelve months EPS of €0.47.

PE Ratio

ESTORIL SOL N has a trailing twelve months price to earnings ratio of 12.66. Meaning, the purchaser of the share is investing €12.66 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.72%.

Volume

Today’s last reported volume for ESTORIL SOL N is 2 which is 99% below its average volume of 200.

Yearly Top and Bottom Value

ESTORIL SOL N’s stock is valued at €5.95 at 22:40 EST, way under its 52-week low of €6.70.

More news about ESTORIL SOL N.

3. VIVORYON (VVY.AS)

6.13% Price Change

Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.

AEX-Index ended the session with VIVORYON rising 6.13% to €2.10 on Wednesday while AEX-Index dropped 0.37% to €924.78.

Earnings Per Share

As for profitability, VIVORYON has a trailing twelve months EPS of €-1.12.

Volatility

VIVORYON’s last week, last month’s, and last quarter’s current intraday variation average was a negative 7.41%, a positive 4.38%, and a positive 7.85%.

VIVORYON’s highest amplitude of average volatility was 7.41% (last week), 12.90% (last month), and 7.85% (last quarter).

More news about VIVORYON.

4. ALMUNDA PRO NV (AMUND.AS)

5.69% Price Change

Almunda Professionals N.V. provides digital transformation, data management, regulatory change, and consultancy services in the Netherlands and internationally. The company was formerly known as Novisource N.V. and changed its name to Almunda Professionals N.V. in August 2021. Almunda Professionals N.V. was founded in 2001 and is headquartered in Amsterdam, the Netherlands.

AEX-Index ended the session with ALMUNDA PRO NV jumping 5.69% to €1.30 on Wednesday while AEX-Index dropped 0.37% to €924.78.

Earnings Per Share

As for profitability, ALMUNDA PRO NV has a trailing twelve months EPS of €0.02.

PE Ratio

ALMUNDA PRO NV has a trailing twelve months price to earnings ratio of 65. Meaning, the purchaser of the share is investing €65 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.14%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 15.7%, now sitting on 27.55M for the twelve trailing months.

Volume

Today’s last reported volume for ALMUNDA PRO NV is 55 which is 88.61% below its average volume of 483.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Jul 10, 2023, the estimated forward annual dividend rate is 0.06 and the estimated forward annual dividend yield is 4.8%.

More news about ALMUNDA PRO NV.

5. ATLANTIC SAPPHIRE (ASA.OL)

5.56% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the production and sale of land-based salmon in Denmark and the United States. The company was incorporated in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE rising 5.56% to €8.89 on Wednesday while Oslo Børs Benchmark Index_GI jumped 0.08% to €1,404.23.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-37.4.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 55.3%, now sitting on 18.95M for the twelve trailing months.

Moving Average

ATLANTIC SAPPHIRE’s value is way higher than its 50-day moving average of kr6.29 and way above its 200-day moving average of kr6.74.

Volume

Today’s last reported volume for ATLANTIC SAPPHIRE is 70900 which is 68.29% below its average volume of 223601.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ATLANTIC SAPPHIRE’s stock is considered to be overbought (>=80).

More news about ATLANTIC SAPPHIRE.

6. OCEANTEAM (OTS.OL)

5.04% Price Change

Oceanteam ASA does not have significant operations. Previously, it engaged in a subsea and offshore business. The company was formerly known as Oceanteam Shipping ASA and changed its name to Oceanteam ASA in December 2015. Oceanteam ASA was incorporated in 2005 and is headquartered in Baerum, Norway.

Oslo Børs Benchmark Index_GI ended the session with OCEANTEAM rising 5.04% to €1.00 on Wednesday, after four successive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.08% to €1,404.23, after two sequential sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, OCEANTEAM has a trailing twelve months EPS of kr-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.79%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, OCEANTEAM’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

OCEANTEAM’s stock is valued at kr1.00 at 22:40 EST, way under its 52-week high of kr2.01 and above its 52-week low of kr0.92.

Revenue Growth

Year-on-year quarterly revenue growth declined by 33.3%, now sitting on 60k for the twelve trailing months.

More news about OCEANTEAM.

7. VÅR ENERGI (VAR.OL)

4.83% Price Change

Vår Energi AS operates as an independent upstream oil and gas company on the Norwegian continental shelf in Norway. It produces crude oil, liquified natural gas, and natural gas liquids. The company was formerly known as Eni Norge AS and changed its name to Vår Energi AS in December 2018. The company was incorporated in 1965 and is headquartered in Sandnes, Norway. Vår Energi AS operates as a subsidiary of Eni International B.V.

Oslo Børs Benchmark Index_GI ended the session with VÅR ENERGI rising 4.83% to €36.27 on Wednesday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.08% to €1,404.23, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, VÅR ENERGI has a trailing twelve months EPS of kr2.14.

PE Ratio

VÅR ENERGI has a trailing twelve months price to earnings ratio of 16.95. Meaning, the purchaser of the share is investing kr16.95 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.31%.

Yearly Top and Bottom Value

VÅR ENERGI’s stock is valued at kr36.27 at 22:40 EST, under its 52-week high of kr39.36 and way higher than its 52-week low of kr26.22.

More news about VÅR ENERGI.

8. UMICORE (UMI.BR)

4.72% Price Change

Umicore SA operates as a materials technology and recycling company in Belgium, rest of Europe, the Asia-Pacific, North America, South America, and Africa. It operates through Catalysis, Energy & Surface Technologies, and Recycling segments. The Catalysis segment provides automotive catalysts for gasoline, and diesel light and heavy-duty diesel applications, including on-road and non-road vehicles; stationary catalysis for industrial emissions control; and produces precious metals-based compounds and catalysts for use in the pharmaceutical and fine chemicals industries, as well as fuel cell applications. The Energy & Surface Technologies segment offers cobalt and specialty materials, rechargeable battery materials, and electro-optic materials, as well as metal deposition solutions, including precious metal-based electroplating and PVD coating. The Recycling segment treats waste streams containing precious and other specialty metals from a range of industrial residues and end-of-life materials. This segment also produces precious metals-based materials for glass production, electric, and electronic applications. The company was formerly known as Union Minière du Haut Katanga and changed its name to Umicore SA in 2001. Umicore SA was founded in 1805 and is headquartered in Brussels, Belgium.

BEL 20 ended the session with UMICORE rising 4.72% to €14.65 on Wednesday while BEL 20 dropped 0.1% to €3,861.38.

Earnings Per Share

As for profitability, UMICORE has a trailing twelve months EPS of €1.6.

PE Ratio

UMICORE has a trailing twelve months price to earnings ratio of 9.16. Meaning, the purchaser of the share is investing €9.16 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.38%.

Yearly Top and Bottom Value

UMICORE’s stock is valued at €14.65 at 22:40 EST, way below its 52-week high of €28.20 and above its 52-week low of €13.41.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, UMICORE’s stock is considered to be oversold (<=20).

More news about UMICORE.

9. HØLAND OG SETSKOG (HSPG.OL)

4.17% Price Change

Høland og Setskog Sparebank provides banking services for the personal and corporate markets in Norway. It offers savings and pension accounts; consumer loans, business loans, mortgage loans, car loans, and loans for motorbikes, ATVs, motorhomes, caravans, snowmobiles, and boats; and refinancing, credit cards, mobile and online banking, bank guarantee, overdrafts, leasing, and factoring and invoice sales, as well as insurance products. The company was formerly known as Holand Sparebank and changed its name to Høland og Setskog Sparebank in 2010. Høland og Setskog Sparebank was founded in 1849 and is headquartered in Bjørkelangen, Norway.

Oslo Børs Benchmark Index_GI ended the session with HØLAND OG SETSKOG rising 4.17% to €124.98 on Wednesday while Oslo Børs Benchmark Index_GI jumped 0.08% to €1,404.23.

Earnings Per Share

As for profitability, HØLAND OG SETSKOG has a trailing twelve months EPS of kr10.75.

PE Ratio

HØLAND OG SETSKOG has a trailing twelve months price to earnings ratio of 11.63. Meaning, the purchaser of the share is investing kr11.63 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.83%.

Volatility

HØLAND OG SETSKOG’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.08%, a negative 0.28%, and a positive 2.79%.

HØLAND OG SETSKOG’s highest amplitude of average volatility was 2.10% (last week), 3.68% (last month), and 2.79% (last quarter).

Sales Growth

HØLAND OG SETSKOG’s sales growth is negative 17.5% for the current quarter and negative 7% for the next.

More news about HØLAND OG SETSKOG.

10. FUT.CLUBE PORTO (FCP.LS)

4% Price Change

Futebol Clube do Porto – Futebol, S.A.D., together with its subsidiaries, participates in professional football competitions, and the sporting events promotion and organization in Portugal. It also engages in the image rights commercialization, sponsoring, merchandising, and products licensing activities; production, editing, and commercialization of multimedia material, as well as Internet, periodical, and non-periodical publications; and sport equipment management and exploration business, as well as insurance broking activities. In addition, the company organizes and sells travel and tour packages; and tickets and seat reservations, as well as represents travel agencies and tourism. Further, it is involved in the concept, design, development, production, direction, promotion, marketing, acquisition, exploration rights, recording, distribution, and dissemination of works and audiovisual programs, multimedia, television, video, cinema, theme, Internet, channels, tourist events, and cultural and sporting in any formats and systems. Additionally, the company manages, operates, and provides services in the areas of recording, production, and communication of audiovisual works, television shows, sounds, images, and other audiovisuals; and edits periodic publicities, books, and multimedia. It also explores for the Porto Canal cable television channel; and produces and executes advertisings, news reports, documentaries, and TV programs in video support. The company was founded in 1893 and is headquartered in Porto, Portugal.

PSI ended the session with FUT.CLUBE PORTO jumping 4% to €1.30 on Wednesday while PSI dropped 0.44% to €6,541.80.

Earnings Per Share

As for profitability, FUT.CLUBE PORTO has a trailing twelve months EPS of €-2.12.

Volume

Today’s last reported volume for FUT.CLUBE PORTO is 506 which is 43.84% below its average volume of 901.

More news about FUT.CLUBE PORTO.

Losers Today

1. BASILIX CERT (BAS.BR)

-7.77% Price Change

Basilix Cert owns and operates a shopping center in Belgium. The company operates accessories, feed, beauty, jewelry, fashion, multimedia, and house shops, as well as restaurants. It offers products of approximately 40 brands. The company was founded in 1984 and is based in Brussels, Belgium. Basilix Cert is a subsidiary of KBC Bank NV. Basilix Cert operates as a subsidiary of KBC Bank NV.

BEL 20 ended the session with BASILIX CERT dropping 7.77% to €9.50 on Wednesday, after five consecutive sessions in a row of losses. BEL 20 slid 0.1% to €3,861.38, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, BASILIX CERT has a trailing twelve months EPS of €-0.52.

More news about BASILIX CERT.

2. ABIONYX PHARMA (ABNX.PA)

-7.63% Price Change

ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. It develops CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is based in Balma, France.

CAC 40 ended the session with ABIONYX PHARMA sliding 7.63% to €1.28 on Wednesday while CAC 40 dropped 0.77% to €7,570.20.

Earnings Per Share

As for profitability, ABIONYX PHARMA has a trailing twelve months EPS of €-0.12.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.11%.

Yearly Top and Bottom Value

ABIONYX PHARMA’s stock is valued at €1.28 at 22:40 EST, way under its 52-week high of €2.38 and way above its 52-week low of €1.05.

More news about ABIONYX PHARMA.

3. ADUX (ADUX.PA)

-6.89% Price Change

AdUX SA provides advertising services in France, Belgium, Italy, Spain, Germany, the Netherlands, and internationally. It provides non-intrusive advertising, in-content advertising, brand content, and geomarketing services. The company was founded in 1996 and is headquartered in Paris, France.

CAC 40 ended the session with ADUX sliding 6.89% to €1.56 on Wednesday, after two consecutive sessions in a row of gains. CAC 40 slid 0.77% to €7,570.20, after two consecutive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, ADUX has a trailing twelve months EPS of €0.36.

PE Ratio

ADUX has a trailing twelve months price to earnings ratio of 4.32. Meaning, the purchaser of the share is investing €4.32 for every euro of annual earnings.

Volume

Today’s last reported volume for ADUX is 11377 which is 20.21% above its average volume of 9464.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ADUX’s stock is considered to be oversold (<=20).

More news about ADUX.

4. AB SCIENCE (AB.PA)

-5.99% Price Change

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company is also developing AB8939, a synthetic microtubule destabiliser for haematology indications. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

CAC 40 ended the session with AB SCIENCE sliding 5.99% to €1.13 on Wednesday, following the last session’s upward trend. CAC 40 fell 0.77% to €7,570.20, after two sequential sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, AB SCIENCE has a trailing twelve months EPS of €-0.2.

More news about AB SCIENCE.

5. CELYAD ONCOLOGY (CYAD.BR)

-5.17% Price Change

Celyad Oncology SA, a biopharmaceutical company, focuses on the research and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. The company is developing shRNA non-gene-edited technology, which allows for the development of allogenic CAR T-cells through the modulation of genes encoding the TCR without the need for gene editing; multi-specific CAR T-cell platform that focuses on the NKG2D receptor; NKG2D-based CAR T-cell therapies; and B7-H6 targeting CAT T-cell therapies. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery/PerkinElmer for the use of its shRNA reagents to reduce expression of one or more defined targets. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with CELYAD ONCOLOGY sliding 5.17% to €0.29 on Wednesday while BEL 20 fell 0.1% to €3,861.38.

Earnings Per Share

As for profitability, CELYAD ONCOLOGY has a trailing twelve months EPS of €-1.36.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CELYAD ONCOLOGY’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for CELYAD ONCOLOGY is 13322 which is 4.52% below its average volume of 13954.

Volatility

CELYAD ONCOLOGY’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.00%, a negative 0.06%, and a positive 2.78%.

CELYAD ONCOLOGY’s highest amplitude of average volatility was 3.22% (last week), 2.20% (last month), and 2.78% (last quarter).

More news about CELYAD ONCOLOGY.

6. ADOCIA (ADOC.PA)

-4.88% Price Change

Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; and BioChaperone LisPram, a combination of prandial insulin with pramlintide, as well as M1Pram, a combination of insulin M1 and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and AdoGel Sema for the long-term delivery of therapeutic agents. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.

CAC 40 ended the session with ADOCIA dropping 4.88% to €7.05 on Wednesday, following the last session’s upward trend. CAC 40 slid 0.77% to €7,570.20, after two consecutive sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, ADOCIA has a trailing twelve months EPS of €-1.9.

More news about ADOCIA.

7. AUTOSTORE HOLDINGS (AUTO.OL)

-4.86% Price Change

AutoStore Holdings Ltd., a robotic and software technology company, provides warehouse automation solutions in Norway, Germany, rest of Europe, the United States, Asia, and internationally. It offers grids, ports, bins, robots, workstations, controllers, and spare parts. The company also provides Qublt Fulfillment Platform, a warehouse management software; PickUpPort that offers frictionless in-store pickup options; ConveyorPort, a workstation that offers access to all bins; Carousel Port which is designed to maintain workstation productivity and coordination between the man and robot; SwingPort that provides work space outside of storage area; RelayPort that offers exchange between man and robot; and FusionPort and FusionPort Staging. It also offers warehouse robots, including R5, R5+, R5 Pro, R5+ Pro, and other products under the Red Line and Black names; Bin ResQ Robot; and Unify Analytics, a cloud-based service and data platform that automates the traditional way of collecting and analyzing real-time log data. In addition, the company offers installation, maintenance, and training of personnel services. It serves retail, grocery, third party logistic, industrial, and healthcare industries. The company was formerly known as AutoStore NewCo Ltd. and changed its name to AutoStore Holdings Ltd. in October 2021. AutoStore Holdings Ltd. was founded in 1996 and is headquartered in Nedre Vats, Norway.

Oslo Børs Benchmark Index_GI ended the session with AUTOSTORE HOLDINGS falling 4.86% to €14.11 on Wednesday, after three sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.08% to €1,404.23, after two sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, AUTOSTORE HOLDINGS has a trailing twelve months EPS of kr-0.11.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.2%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AUTOSTORE HOLDINGS’s stock is considered to be overbought (>=80).

Moving Average

AUTOSTORE HOLDINGS’s worth is way below its 50-day moving average of kr23.72 and way below its 200-day moving average of kr22.05.

Sales Growth

AUTOSTORE HOLDINGS’s sales growth is negative 88% for the current quarter and negative 87% for the next.

More news about AUTOSTORE HOLDINGS.

8. ARTEA (ARTE.PA)

-4.64% Price Change

Artea SA operates as a real estate development company in France. It develops tertiary parks, emblematic projects, urban office buildings, eco-neighborhoods, hotels, shops, and housing projects. The company also generates and supplies electrical power using renewable sources, such as photovoltaics and hydraulics. Artea SA was founded in 2001 and is headquartered in Paris, France.

CAC 40 ended the session with ARTEA sliding 4.64% to €9.25 on Wednesday while CAC 40 slid 0.77% to €7,570.20.

Earnings Per Share

As for profitability, ARTEA has a trailing twelve months EPS of €-1.08.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ARTEA’s stock is considered to be overbought (>=80).

More news about ARTEA.

9. ARRIBATEC GROUP (ARR.OL)

-4.46% Price Change

Arribatec Group ASA, a software and consulting company, provides digital business solutions in Norway, Europe, the Americas, and internationally. The company offers solutions for businesses, including ERP systems, integrations, consulting, health checks, develops, HR and payroll, financial and project planning, bank solutions, and travel and expenses. Its solutions include QualiWare, a management system that structures and visualizes processes, activities, regulations, and requirements; Unit4 solutions; RamBase, an ERP business solution that gives control over the value chain; Power BI solutions; Hypergene, a business management tool; Adra Suite that integrates with other financial systems; Microsoft 365; CatalystOne; and Pagero that ensures compliance with legal and electronic billing requirements. Arribatec Group ASA was incorporated in 1998 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ARRIBATEC GROUP falling 4.46% to €4.28 on Wednesday while Oslo Børs Benchmark Index_GI jumped 0.08% to €1,404.23.

Earnings Per Share

As for profitability, ARRIBATEC GROUP has a trailing twelve months EPS of kr-0.37.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.94%.

Volume

Today’s last reported volume for ARRIBATEC GROUP is 46157 which is 65.65% below its average volume of 134391.

More news about ARRIBATEC GROUP.

10. HYDROGENPRO (HYPRO.OL)

-4.31% Price Change

HydrogenPro ASA engages in designing and delivering hydrogen technology and systems in Norway, Europe, the United States, and the Asia Pacific. It offers high-pressure alkaline electrolyzers. The company serves synthetic aviation fuel, refinery/decarbonization, power to gas, balancing the grid, steel production, fertilizer/ammonia, and shipping markets. HydrogenPro ASA was incorporated in 2013 and is headquartered in Porsgrunn, Norway.

Oslo Børs Benchmark Index_GI ended the session with HYDROGENPRO sliding 4.31% to €10.22 on Wednesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.08% to €1,404.23, after two successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, HYDROGENPRO has a trailing twelve months EPS of kr-1.48.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.59%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 290.9% and a negative 21.2%, respectively.

More news about HYDROGENPRO.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *